2-Bromopropane → 2-Fluoro-9-isopropyl-N-((6-methylpyridin-3-yl)methyl)-9H-purin-6-amine

To a stirred solution of 2-fluoro-N-(6-methylpyridin-3-yl)methyl-9H-purin-6-amine (0.3 g, 1.17 mmol) in dimethylformamide (10 ml) at room temperature under an argon atmosphere, was added powdered, anhydrous K2CO3 (0.8 g, 5 eq, 5.85 mmol), followed by 2-bromopropane (1.15 ml, 11.7 mmol). The reaction mixture was stirred at room temperature for 24 h, when DCM:ether:MeOH (55:40:5), indicated that the reaction had gone to completion. The solvent was evaporated in vacuo and the residue partitioned between EtOAc (100 ml) and water (100 ml). The aqueous phase was extracted with more EtOAc (2×50 ml) and the combined organic phase washed with brine (50 ml), dried (MgSO4) and evaporated in vacuo. The residue was purified by silica gel flash column chromatography, eluted with CHCl3:MeOH (98:2) to afford the title compound as a slightly yellow film (195 mg, 55%). δH (CDCl3, 250 MHz) 1.52 (6 H, d, J 7.5, CH[CH3]2), 2.5 (3 H, s, CH3), 4.76-4.6 (3 H, m, NHCH2 and CHMe2), 7.06 (1 H, d, J 2.5, ArH), 7.35 (1 H, s, br, NH), 7.56 (2 H, s, br, ArH), 8.47 (1 H, s, br, ArH); δC (CDCl3, 250 MHz) 157.6 (C), 156.32 (C), 156 (C), 148.47 (CH), 137.72 (CH), 136.08 (CH), 130.83 (C), 123.11 (CH), 118.2 (C), 47.38 (CH), 43.2 (CH2), 23.99 (CH3), 22.5 (2×CH3); m/z 301.2 (M+H)

1. customThe solvent was evaporated in vacuo
2. customthe residue partitioned between EtOAc (100 ml) and water (100 ml)
3. extractionThe aqueous phase was extracted with more EtOAc (2×50 ml)
4. washthe combined organic phase washed with brine (50 ml)
5. dry with materialdried (MgSO4)
6. customevaporated in vacuo
7. customThe residue was purified by silica gel flash column chromatography
8. washeluted with CHCl3:MeOH (98:2)

ORD 기록

ord-968e1434b45846c5a1b71213b0b8fa84

출처 데이터셋

uspto-grants-2013_11

DOI

10.6084/m9.figshare.5104873.v1

특허 번호

US08592581B2